Healthcare Stocks Quietly Outperform as Investors Rotate Out of Tech and Into Defensive Plays

While the financial press obsesses over the latest AI flameout and the Nasdaq’s existential crisis, something quietly bullish is happening in the background: healthcare stocks are holding their ground, and in some cases, quietly outperforming. As of February 26, 2026, XLV is parked at $157.36, flat on the day, but that’s the point. In a market where tech stocks are getting tossed around like a meme coin in a rug pull, healthcare is the sector that refuses to break.

The narrative is shifting. Tech and AI were supposed to be the only game in town, but as institutional flows cool and the software sector gets downgraded, money is rotating into sectors with real cash flow and defensible moats. Enter healthcare. The sector isn’t sexy, but it’s profitable, and in a market obsessed with “what’s next,” sometimes what’s next is just not losing money. XLV’s resilience is a feature, not a bug.

The numbers back it up. Over the past month, XLV has outperformed both the Nasdaq 100 and the S&P 500 on a risk-adjusted basis. Volatility is low, and the sector’s beta is dropping as funds pile in for safety. According to Barron’s (2026-02-26), veteran strategists are calling for a new bull market in long-neglected sectors, with healthcare at the top of the list. The rotation is subtle, but the flows are real. If you’re still chasing tech, you’re missing the trade that’s actually working.

Historically, healthcare outperforms during late-cycle rotations and periods of macro uncertainty. With global fragmentation on the rise and the Fed’s credibility in question (see Seeking Alpha’s critique of premature rate cuts), investors are looking for sectors that can weather the storm. Healthcare fits the bill. The sector’s earnings are stable, margins are fat, and regulatory risk is mostly priced in. The last time we saw a similar setup was in 2016, when XLV rallied 18% over six months while tech went sideways.

The absurdity here is that most traders are still ignoring healthcare, waiting for the next AI headline to bail them out. Meanwhile, the smart money is quietly building positions in XLV and its components. The algos have noticed. Every dip is getting bought, and the tape is clean. There’s no FOMO, just steady accumulation. This is what real sector rotation looks like.

Strykr Watch

Technically, XLV is consolidating above $155, with resistance at $160 and support at $153. The 50-day moving average is sloping up, and RSI is holding above 55. If XLV breaks above $160, the next target is $167, where the sector last topped out before the 2025 tech melt-up. The volume profile shows steady institutional buying, and options flow is skewed bullish. Keep an eye on the $155 level, if that breaks, the rotation thesis is in trouble, but for now, the path of least resistance is higher.

The sector’s implied volatility is low, but that’s the opportunity. As tech volatility spikes, healthcare’s calm is attracting more capital. Watch for a pickup in momentum if macro data disappoints or if another tech earnings miss triggers a broader selloff. XLV is the safety trade, and the market knows it.

The risk is that a sudden regulatory shock or a major earnings miss could derail the sector, but those are tail risks, not base case scenarios. The Strykr Pulse is a healthy 68/100, and Threat Level is a manageable 2/5. This is a market where boring is beautiful.

On the opportunity side, buying dips near $155 with stops below $153 offers a solid risk-reward. Selling puts or buying call spreads into strength is another way to play the rotation. If XLV breaks above $160, momentum traders will pile in. Don’t wait for the headlines, this trade is happening under the radar.

Strykr Take

Healthcare is the sector that everyone ignores until it’s too late. The rotation out of tech and into defensives is real, and XLV is leading the charge. In a market obsessed with the next big thing, sometimes the best trade is the one that just keeps working. Ignore healthcare at your own risk. This is where the smart money is hiding.